Navigation Links
Lenalidomide, Granted Approval by FDA to Join Multiple Myeloma Drugs

Graham Burton, M.D., SVP, Regulatory Affairs and Pharmacovigilance said that FDA’s approval of REVLIMID (lenalidomide) offered a new oral drug option// to the group of people suffering from multiple myeloma.

Celgene Corporation (Nasdaq: CELG) announced that the U.S. Food and Drug Administration (FDA) has granted approval for its Supplemental New Drug Application (sNDA) for an additional indication for REVLIMID (lenalidomide), for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy. REVLIMID is also approved for use in the treatment of patients with transfusion-dependent anemia due to Low-or- Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Multiple myeloma is the second most common blood cancer in the United States, affecting approximately 50,000 people. About 14,600 new cases of multiple myeloma are diagnosed each year and about 12,000 Americans are expected to die of multiple myeloma in 2006. In the REVLIMID (lenalidomide)/dexamethasone treatment group, 151 patients (45%) underwent at least one dose interruption with or without a dose reduction of REVLIMID (lenalidomide) compared to 21% in the placebo/dexamethasone treatment group. Most adverse events and Grade 3 or 4 adverse events were more frequent in patients who received the combination of REVLIMID (lenalidomide)/dexamethasone compared to placebo /dexamethasone.

‘The FDA approval of REVLIMID offers a new oral therapeutic option to this particular group of patients with multiple myeloma,’ said Graham Burton, M.D., SVP, Regulatory Affairs and Pharmacovigilance for Celgene. REVLIMID will be available in the following strengths: 5 mg, 10 mg, 15 mg, and 25 mg capsules.

Source: Eurekaler
'"/>




Page: 1

Related medicine news :

1. Bail Granted To The Doctor Despite Her Patients Death
2. Azerbaijan Granted 5 million dollars in Fight Against Bird Flu
3. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
4. American Senior Citizens Granted More Time
5. Numerous Defense Personnel Granted Early Retirement Due to Mental Illness
6. Approval for DNA test to detect cystic fibrosis
7. Vaccine For Cervical Cancer Awaits Approval
8. WHO Gives Its Approval For Bird Flu Test Kit
9. FDA Gives Its Approval For Inhaler
10. RotaTeq Gets US Approval
11. Better Communication With FDA Could Speed Up Approval Of New Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and oldest ... SAS will provide researchers worldwide with data management and analytics tools to explore 45 ... The DCRI and SAS share the goal of greater transparency and openness in research ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... April 2016. SS&A teamed up with one of the top website design companies ... portal contains informative legal articles related to the law firm's main practice areas. ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, ... same-day LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her ... surgery the same day as her in-office consultation and eye exam. Francesca’s eyesight was ...
(Date:5/4/2016)... ... May 04, 2016 , ... Advanced Spine & Sport ... restore its patients’ health, is hosting a free seminar on stem cell injections. The ... at Advanced Spine & Sport, 4601 Telephone Road, Suite 110, Ventura, CA. There are ...
(Date:5/4/2016)... ... 2016 , ... Mediware Information Systems, Inc . has ... helps blood and marrow transplant (BMT) programs meet compliance and accreditation standards while ... to enhance core application features. These enhancements are designed to help BMT programs ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Ischemic Stroke Market ... to their offering.       (Logo: ... Global Acute Ischemic Stroke Market and Competitive ... Acute Ischemic Stroke pipeline products, Acute Ischemic ...
(Date:5/3/2016)... May 3, 2016 BioNovus Innovations LLC ... for Advancing Medical Innovation (IAMI) today announced a ... diagnostics and medical devices. An agreement ... rights to license, develop and commercialize medical innovations ... "This partnership represents a significant advance in ...
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
Breaking Medicine Technology: